Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Griptha Putra Persada Tbk. (GRPH) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance

Griptha Putra Persada Tbk.Trade
Tempo Scan Pacific Tbk.Trade

Price performance (Past 24H)

Key statistics

Griptha Putra Persada Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Griptha Putra Persada Tbk. trades at Rp63 (market cap 63B, 3.18M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,780 (market cap 12.58T, 235.2K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 199.7× Griptha Putra Persada Tbk.'s market cap, and Griptha Putra Persada Tbk. is more actively traded (3.18M versus 235.2K). Which is the better fit depends on your goals.

GRPHTSPC
Market Cap
63B12.58T
Volume
3.18M235.2K
Lot
31.8K2.35K
Turnover
200.21M649.94M
Average Price
62.972,763.37
Value
200.21M649.94M
Indicative Equilibrium Price
632,780
Indicative Equilibrium Volume
2629

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

GRPH
View details
TSPC
View details

About Griptha Putra Persada Tbk.

PT Griptha Putra Persada Tbk (the Company), was established based on Notarial Deed No. 26 dated April 14, 2010 of Drs. Ika Slamet Riyono, S.H., notary in Kudus. The Company started its commercial operation in July 1, 2015. The Company’s immediate parent company is PT Mulia Jaya Palma and the ultimate controlling shareholder of the Company is Samuel Jeffrey Christiawan Soegeng.

Read more on GRPH

About Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Read more on TSPC